Dr. Kjell Stenberg, COO
 |
Dr. Stenberg holds a Ph.D. from the Karolinska Institute, Sweden and has published extensively in the field of oncology and cell toxicology. From 1975 to 2000, Dr. Stenberg held senior research and management positions at Astra and AstraZeneca (which as a merged entity is one of the largest pharmaceutical companies in the world), where his responsibilities included the directing of research in multiple sclerosis. Most recently, Dr. Stenberg was the director of external alliances for the development of products related to the Central Nervous System, with wide responsibilities for the identification, negotiation and management of in-licensing projects in that area (which included multiple sclerosis). |